Myomo Receives Grant to Develop Pediatric Device
Myomo, Cambridge, Massachusetts, has received a $50,000 seed grant from the Philadelphia Pediatric Medical Device Consortium (PPDC) to develop the MyoPro Motion-K. The MyoPro Motion-K, a pediatric-size version of the MyoPro device, assists with motion and function in children with neuromuscular disorders. Myomo was one of three companies chosen from eight finalists in the competition.
"We are once again delighted to support promising, innovative medical devices geared to the unmet clinical needs of children," said engineer Matthew R. Maltese, PhD, of the Children's Hospital of Philadelphia, the consortium's executive director and principal investigator.
The PPDC, a collaboration between the Children’s Hospital of Philadelphia, Drexel University, and the University of Pennsylvania, is funded by the U.S. Food and Drug Administration and helps innovators translate promising ideas into commercial medical devices for use in children.
"We are once again delighted to support promising, innovative medical devices geared to the unmet clinical needs of children," said engineer Matthew R. Maltese, PhD, of the Children'’'s Hospital of Philadelphia, the consortium'’'s executive director and principal investigator.
About Myomo, Inc.
Myomo, Inc. is a medical robotics company leading the way in
providing myoelectric-controlled, powered braces (orthotics) that support weakened
extremities. The company's myoelectric orthotics have been prescribed to help support a
limb and restore function by enabling individuals with various neurological conditions to self-
initiate and control movement of their partially paralyzed limbs using their own muscle
signals. The Myomo technology was originally developed at Massachusetts Institute of
Technology in collaboration with medical experts affiliated with Harvard Medical School.
The company is headquartered in Cambridge, Mass
Myomo Contact Information:
Contact: Alan Weinberg
Phone: 877 736 9666